期刊文献+

microRNA-709负性调控线粒体功能参与肾小管上皮细胞损伤 被引量:1

Negative regulation of microRNA - 709 in mitochondrial function participating in the renal tubular epithelial cell injury
原文传递
导出
摘要 目的探讨microRNA-709(miR-709)在顺铂引起肾小管上皮细胞损伤模型中的作用及机制。方法体外培养小鼠肾小管上皮细胞,予不同浓度(0、1、5、10、20μmol/L)顺铂刺激24h,以10μmol/L顺铂刺激不同时间(0、2、6、12、24h)。采用实时荧光定量PCR(RT—PCR)技术检测细胞miR-709的表达变化。实验组分为上调对照组、miR-709过表达组、下调对照组、miR-709下调组,其中miR-709下调组和下调对照组加顺铂刺激。应用AnnexinV—FITC/PI双染法检测细胞凋亡,分光光度法检测含半胱氨酸的天冬氨酸水解酶(Caspase-3)活性,Westernblot法和RT—PCR检测上皮细胞标志蛋白E-cadherin及其mRNA的变化。JC-1(线粒体膜电位)荧光探针检测线粒体膜电位,流式细胞术检测线粒体超氧化物(mltoSOX)生成,PCR检测线粒体基因(mtDNA)拷贝数。结果miR-709在5μmol/L顺铂刺激小管上皮细胞后开始明显升高(F=22.17,P〈0.05),10μmol/L顺铂刺激12h开始明显升高(F=33.462,P〈0.05);过表达miR-709后细胞凋亡数目、Caspase-3活性较上调对照组增加,E-cadhenn表达较上调对照组下降,差异均有统计学意义(凋亡:1.54±0.20比1.00±0.23;Caspase-3活性:1.27±0.08比0.97±0.08;E-cadherin:0.47±0.15比1.00±0.10;t=-3.086、-5.882、5.671,P均〈0.05);线粒体功能指标线粒体膜电位、mtDNA拷贝数较对照组降低,mitoSOX生成较对照组增加,差异均有统计学意义(JC-1:0.80±0.04比1.05±0.08;mtDNA:0.58±0.15比1.00±0.75;mitoSOX:1.31±0.16比1.00±0.05;t=4.687、4.943、-3.694,P均〈0.05)。而顺铂刺激后,miR-709下调组细胞凋亡数目、Caspase-3活性较下调对照组降低,E—cadhefin表达较下调对照组增高,差异均有统计学意义(凋亡:1.35±0.10比1.86±0.44;Caspase-3活性:1.04±0.12比1.30±0.09;E-cadhefin:0.86±0.08比0.54±0.05;F=18.489、20.932、33.323,P均〈0.05);线粒体膜电位、mtDNA拷贝数较对照组增加,mitoSOX生成较下调对照组降低,差异均有统计学意义(Jc-1:0.94±0.06比0.75±0.05;mtDNA:0.68±0.09比0.27±0.12;mitoSOX:0.91±0.09比1.22±0.08;F=21.726、59。330、23.813,P均〈0.05)。结论miR-709可能通过负性调控线粒体功能参与顺铂引起的肾小管上皮细胞损伤。 Objective To investigate the role of microRNA -709 (miR -709)in murine renal tubular epithe- lial cells with Cisplatin treatment and its underlying mechanism. Methods The ceils were cultured with Cisplatin in the concentrations (0,1,5,10,20 μmol/L) for 24 h in vitro,and underwent 10 μmol/L Cisplatin stimulation at diffe- rent time points ( 0,2,6,12,24 h). Real - time fluorescence quantitative polymerase chain reaction ( RT - PCR) was used to investigate the level of miR - 709. mPTC were divided into a negative control group, miR - 709 mimic group, in- hibitor negative control (INNC) group, miR - 709 inhibitor group, INNC group and miR - 709 inhibitor group were trea- ted with Cisplatin treatment. Annexin V - FITC/PI double staining was applied to detect apoptosis. Caspase - 3 activity was detected by spectrophotometry. The mRNA and protein levels of E - cadherin were detected by RT - PCR and Western blot. Mitochondrial membrane potential and mitochondrial superoxide (mitoSOX) generation were detected by flow cytometry. Mitochondrial DNA(mtDNA) copy number was verified by PCR. Results The level of miR -709 in- creased in Cisplatin 5 μmol/L stimulation group( F = 22. 17 ,P 〈 0.05 ) and increased further 12 h later after cultured in 10 μmol/L Cisplatin compared with that of the control group ( F = 33. 462, P 〈 0. 05 ). After overexpression of miR - 709, apoptotic rate and Caspase - 3 activity of the mPTC increased, while the expression of E - cadherin declined when compared with that in the negative control group ( apoptotic rate : 1.54 ± 0.20 vs 1.00± 0. 23 ; Caspase - 3 activity:1.27±0.08vs0.97 ±0.08;E-cadherin:0.47±0.15 vs 1.00±0.10;t= -3.086, -5.882,5.671,allP〈 0.05 ). In addition, the levels of JC - 1 and mtDNA decreased while mitoSOX increased compared with that of the con-trol group (JC - 1:0.80 ±0.04 vs 1.05 ±0. 08;mtDNA:0.58 ±0. 15 vs 1.00 ±0.75;mitoSOX: 1.31 ±0. 16 vs 1.00 ± 0.05 ; t = 4. 687,4. 943, - 3. 694, all P 〈 0.05 ). Downregulation of miR - 709 attenuated the tubular cell injury and the mitochondrial dysfunction was induced by Cisplatin ( apoptotic rate : 1.35 ± 0.10 vs 1.86± 0.44 ; Caspase - 3 activity : 1.04 ±0.12 vs 1.30 ± 0.09 ; E - cadherin :0.86 ± 0.08 vs 0. 54 ±0.05 ; JC - 1:0.94± 0.06 vs 0. 75 ± 0.05 ; mtDNA :0.68 ± 0.09 vs 0. 27 ± 0.12 ; mitoSOX : 0.91 ± 0.09 vs 1.22 ± 0.08 ; F = 18. 489,20. 932,33. 323,21. 726, 59.330,23. 813, all P 〈 0.05 ). Conclusion Mitochondrial function negatively regulated by miR - 709 may be involved in the renal tubular epithelial cell injury induced by Cisplatin.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2015年第9期711-714,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(81170635)
关键词 顺铂 线粒体功能 microRNA-709 肾小管上皮细胞损伤 Cisplatin Mitochondrial function MicroRNA - 709 Renal tubular epithelial cell injury
  • 相关文献

参考文献2

二级参考文献29

  • 1Kidney Disease Improving Global Outcomes KDIGOAcute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for acute kidney injury[J].Kidney International,2012,(Suppl 2):1-138.
  • 2Mehta RL,Kellum JA,Shah SV. Acute kidney injury network:report of an initiative to improve outcomes in acute kidney injury[J].Critical Care,2007,(02):R31.
  • 3Akcan-Arikan A,Zappitelli M,Loftis LL. Modified RIFLE criteria in critically ill children with acute kidney injury[J].Kidney International,2007,(10):1028-1035.doi:10.1038/sj.ki.5002231.
  • 4Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood[J].Blood Purification,2012,(1-3):131-137.
  • 5Tsigou E,Psallida V,Demponeras C. Role of new biomarkers:functional and structural damage[J].Crit Care Res Prcat,2013.361078.
  • 6Honore PM,Jacobs R,Joannes-Boyau O. Biomarkers for early diagnosis of AKI in the ICU:ready for prime time use at the bedside[J].Annals of Intensive Care,2012,(01):24.
  • 7Zarychanski R,Abou-Setta AM,Turgeon AF. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation:a systematic review and meta-analysis[J].Journal of the American Medical Association,2013,(07):678-688.
  • 8Zappitelli M,Goldstein SL,Symons JM. Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy:a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group[J].Critical Care Medicine,2008,(12):3239-3245.doi:10.1097/CCM.0b013e31818f3f40.
  • 9Tsagalis G. Update of acute kidney injury:intensive care nephrology[J].Hippokratia,2011,(Suppl 1):S53-S68.
  • 10Basu RK,Wheeler DS. Approaches to the management of acute kidney injury in children[J].Recent Pat Biomark,2011,(01):49-59.

共引文献43

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部